Carole Ben-maimon, President and CEO at Larimar Therapeutics, Inc. (LRMR), bought 5,000 shares at $3.71 ($19K) on 2023-05-17, disclosed to the SEC on 2023-05-18.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| TLGT | BUY | 2017-11-13 | $17K | — | Filing → |